Influenza Vaccination

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Approval
FDA sign
FDA Approval
FDA Approves mFLUSIVA for Influenza Prevention in Adults Aged 50 Years and Older
08/07/2026
Anthony Calabro, MA
The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.
08/07/2026
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
Influenza Vaccine
Influenza Vaccine
FDA Issues 2018-2019 Flu Vaccine Recommendations
03/02/2018
The US Food and Drug Administration advisory committee has released its recommendations regarding the components of the 2018-2019 influenza vaccine.
03/02/2018